Royalty Pharma plc
RPRX
Peringkat dalam Saham
#865
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Harga Saham
$62.21
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$27.70B
Perubahan (1 hari)
3.22%
Perubahan (1 tahun)
65.98%
Negara
US
Perdagangan Royalty Pharma plc (RPRX)
Kategori
Healthcare
Jumlah saham beredar untuk Royalty Pharma plc (RPRX)
Jumlah saham beredar per June 2026: 445.06M
Menurut laporan keuangan terbaru dan harga saham Royalty Pharma plc, jumlah saham beredar saat ini adalah 445.06M. Pada akhir December 2024, perusahaan memiliki 445.99M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Royalty Pharma plc (RPRX) dari 2015 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 445.06M | 3.55% |
| 2025 | 429.80M | -3.63% |
| 2024 | 445.99M | -0.36% |
| 2023 | 447.60M | 2.20% |
| 2022 | 437.96M | 5.59% |
| 2021 | 414.79M | 6.87% |
| 2020 | 388.14M | 9.59% |
| 2019 | 354.18M | 0.00% |
| 2018 | 354.18M | 0.00% |
| 2017 | 354.18M | -41.65% |
| 2016 | 607.04M | 0.00% |
| 2015 | 607.04M | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 105.38M | -76.32% |
US
|
|
| 18.05B | 3,955.26% |
HK
|
